Partner

At a glance

25

Finished Products

7

Therapy Areas

8+

Delivery Formats

C3-CURA™

Primary Platform

All ingredients
CurcuminIngredient · 01/14

Curcumin

Diferuloylmethane (Curcumin)

Market Landscape

The opportunity – and where the market falls short.

  • 01Clinically Proven – strong anti-inflammatory, multi-pathway activity
  • 02Broad Use Cases – pain, metabolic, dermatology, women's health
  • 03High Acceptance – trusted, widely used natural ingredient
  • 04Limited Innovation – capsule-dominated formats
  • 05Generic Positioning – focused on immunity and general wellness
The Stabicon Edge

From market limitation to measurable transformation.

Market LimitationStabicon TransformationImpact
Poor BioavailabilityEnhanced Absorption (C3-CURA™ ~500× bioavailability, water-soluble)Significantly higher systemic availability
High Dose DependencyLow-Dose EfficiencyReduced dosage with improved therapeutic outcomes
Limited FormatsMulti-Format Expansion – oral, topical, transdermal, mouth-melt, effervescentBroader product applicability and consumer reach
Weak Clinical PositioningTargeted Applications – pain, metabolic, dermatology, women's healthStronger indication-led positioning
Inconsistent ResultsReliable EfficacyConsistent real-world performance
Commoditized MarketPlatform Differentiation – C3-Flex, C3-Force, Diagard ecosystemScalable, premium, defensible portfolio
Stabicon's Portfolio

Curcumin reimagined across therapy areas and delivery formats.

25 finished formulations powered by Curcumin, organised across 7 therapy categories.

25

Products

07

Therapy Areas

08+

Formats

01 · Joint • Soft-tissue • Topical • Patch

Pain & Inflammation

Explore category

07 · Oral care • Mucosal • Respiratory wellness

Oral & Respiratory Health

Explore category
Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Unsubscribe in one click. Your email stays with us.

Press Kit

Logos, fact sheet & spokesperson bios – all in one download.

Download Press Kit (ZIP)

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.